![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 29, 2020 12:24:35 PM
Recent AKBA News
- Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference • PR Newswire (US) • 06/27/2024 12:18:00 PM
- Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer • PR Newswire (US) • 06/24/2024 12:58:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:20:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:20:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:19:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:32 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference • PR Newswire (US) • 05/23/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:04:58 PM
- Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference • PR Newswire (US) • 05/14/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2024 11:19:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2024 11:17:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 09:27:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:05:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:03:22 AM
- Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 05/09/2024 11:00:00 AM
- Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights • PR Newswire (US) • 05/02/2024 12:30:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/01/2024 08:05:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/02/2024 08:05:00 PM
- Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis • PR Newswire (US) • 03/28/2024 12:26:00 AM
- Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/14/2024 08:15:00 PM
- Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/11/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:48:25 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM